Home |
Free Dividend Report |
Stock Splits Calendar |
CYTK Historical Stock Prices |
Preferred Stock Newsletter |
CYTK Options Chain |
Stock Message Boards |
Cytokinetics (CYTK) has the following price history information. Looking back at CYTK historical stock prices for the last five trading days, on April 19, 2024, CYTK opened at $66.88, traded as high as $67.80 and as low as $64.82, and closed at $67.55. Trading volume was a total of 1.61M shares. On April 22, 2024, CYTK opened at $67.90, traded as high as $67.90 and as low as $65.64, and closed at $66.29. Trading volume was a total of 1.18M shares. On April 23, 2024, CYTK opened at $66.72, traded as high as $68.76 and as low as $65.53, and closed at $65.57. Trading volume was a total of 1.28M shares. On April 24, 2024, CYTK opened at $65.89, traded as high as $67.45 and as low as $65.68, and closed at $66.82. Trading volume was a total of 807.80K shares. On April 25, 2024, CYTK opened at $64.81, traded as high as $65.42 and as low as $63.90, and closed at $64.80. Trading volume was a total of 1.11M shares.
CYTK Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cytokinetics shares, starting with a $10,000 purchase of CYTK, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2014 | |
End date: | 04/25/2024 | |
Start price/share: | $4.54 | |
End price/share: | $64.80 | |
Dividends collected/share: | $0.00 | |
Total return: | 1,327.31% | |
Average Annual Total Return: | 30.46% | |
Starting investment: | $10,000.00 | |
Ending investment: | $142,710.97 | |
Years: | 10.00 |
CYTK Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/19/2024 | $66.88 | $67.80 | $64.82 | $67.55 | 1.61M |
04/22/2024 | $67.90 | $67.90 | $65.64 | $66.29 | 1.18M |
04/23/2024 | $66.72 | $68.76 | $65.53 | $65.57 | 1.28M |
04/24/2024 | $65.89 | $67.45 | $65.68 | $66.82 | 807.80K |
04/25/2024 | $64.81 | $65.42 | $63.90 | $64.80 | 1.11M |
About Cytokinetics |
Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor. |
CYTK Historical Closing Prices | |
Date | Close |
04/19/2024 | $67.55 |
04/22/2024 | $66.29 |
04/23/2024 | $65.57 |
04/24/2024 | $66.82 |
04/25/2024 | $64.80 |
Healthcare Historical Prices |
CYTK is categorized under the Healthcare sector; below are some other companies in the same sector:
CYTR Historical Stock Prices Also explore: CYTK shares outstanding history
Free CYTK Email Alerts:
|
CYTK Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.